1. Search Result

Search Result

Results for "358970-97-5" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-14788
    Drinabant

    AVE1625

    Cannabinoid Receptor Metabolic Disease
    Drinabant (AVE1625) is an orally active CB1 receptor antagonist. Drinabant (AVE1625) inhibits the agonist-stimulated calcium signal with IC50 values of 25 nM and 10 nM for the hCB1-R and rCB1-R, respectively, and is ineffective for the hCB2-R.